As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios, focusing on high-priority digital transformation initiatives, and seeking providers with specialized domain knowledge, agility, and life sciences-specific technical expertise. Additionally, niche providers are emerging in the post-pandemic era and gaining traction in the digital services market. This compendium provides detailed and fact-based snapshots of 16 life sciences digital service providers. Each profile offers a comprehensive picture of the provider’s offerings, technology solutions, key clients, recent developments, and investments. Scope Industry: life sciences Geography: global Contents This report features 16 life sciences digital service provider profiles and includes: Company overview: the company’s mission, client base, and revenue split across buyer segment and geographies Case studies demonstrating digital service provider capabilities Solutions/Products enabling digital service provider capabilities Recent product developments, partnerships, and investment areas Membership(s) Life Sciences Information Technology Sourcing and Vendor Management

In the rapidly evolving life sciences landscape, where the pursuit of innovative therapies and life-saving drugs never ceases, science and technology are increasingly playing a vital role. High-performance Computing (HPC) stands at the forefront of this technology revolution, empowering pharmaceutical and medical device enterprises, as well as research and academia, to unravel the complexities of biology, medicine, and multi-omics like never before. HPC is no longer confined to successful pilot phases but is transitioning to wider adoption, addressing essential business needs across industries, including life sciences. The pharmaceutical industry, dealing with vast volumes of complex and heterogenous data, is an ideal sector for harnessing the benefits of HPC – particularly around intricate biological interactions, complex data analysis, and sophisticated simulations. In this viewpoint, we study HPC’s high-potential use cases in life sciences and how pharmaceutical companies can derive success from their HPC initiatives. Scope Industry: life sciences Geography: global Contents In this report, we explore: HPC’s evolution, including the examination of an HPC-enabled system and the catalysts driving its adoption across industries The current supply ecosystem, highlighting prominent pharmaceutical and medical device HPC use cases The drivers and barriers to HPC adoption and important enterprise considerations before transitioning to HPC A step-based adoption roadmap for life sciences enterprises and a peek into HPC’s future in life sciences Membership(s) Life Sciences Information Technology Outsourcing Excellence

As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios, strategically addressing high-priority quick-wins use cases for digital transformation, and actively seeking providers with greater domain knowledge, enhanced agility, and life sciences-specific technical expertise. Niche providers are emerging in the post-pandemic era and are establishing a strong presence in the digital services market. In this report, we assess 16 providers featured on the Life Sciences Digital Services Specialists PEAK Matrix®. Each profile offers a comprehensive picture of the provider’s service focus, key Intellectual Property (IP) / solutions, domain investments, and case studies. The study will enable buyers to choose the best-fit provider based on their sourcing considerations, while providers will be able to benchmark their performance against each other. Scope   Industry: life sciences IGeography: global IThe assessment is based on Everest Group’s annual RFI process for calendar year 2023, interactions with leading life sciences digital service providers, client reference checks, and an ongoing analysis of the life sciences digital services market Contents In this report, we closely examine the life sciences digital services specialists state of the market while focusing on the following aspects: Major segments of specialist service providers based on their capabilities in the life sciences digital services space Role of specialist providers as enterprises move to a new sourcing model Tenets of the unique value proposed by specialists to carve out a niche for themselves Membership(s) Life Sciences Information Technology Outsourcing Excellence

Amid the global COVID-19 pandemic, the Life Sciences (LS) industry faced unprecedented challenges that prompted the accelerated adoption of IT services across its value chain. To ensure business continuity, LS enterprises swiftly embraced virtual ecosystems facilitated by IT services. They have actively adopted digital transformation, leading to a surge in the utilization of emerging technologies such as cloud migration, virtual engagement models for clinical trials and sales and marketing, AI/ML for drug discovery, digital twins for manufacturing, real-time IoT visibility for supply chain, and cybersecurity for connected medical devices. Moreover, LS enterprises are prioritizing provider rationalization and IT rationalization to optimize costs and address pricing pressures. Although the LS industry has traditionally been slow in adopting IT, enterprises have embarked on their digital transformation journeys by implementing a digital thread to support and foster emerging use cases. These enterprises seek thought leaders and innovation partners capable of guiding them through their transformation endeavors. Consequently, providers are enhancing their capabilities by developing industry-specific tools and accelerators, as well as engaging in LS-specific partnerships and co-innovation initiatives. In this report, we examine the principal enterprise themes and provide an overview of the general LS IT services market outlook for 2023. Scope Industry: LS Geography: global Contents In this report, we examine: Key enterprise themes that dominated the LS market in 2022 The current market for LS IT services and its projected growth LS IT services deals that are up for renewal The market outlook for 2023 and subsequent years Membership(s) Life Sciences Information Technology Sourcing and Vendor Management

Core administrative operations are a vital component of healthcare plan and payer organizations. However, with the increasing complexity of delivery and implementation options, the legacy Core Administration Processing Solution (CAPS) falls short. The key core administrative functions include benefits administration, claims processing, member enrollment, claims payment and adjustments, and product management for benefits and product lines. While the legacy system provides a stable environment that can be customized to fit the customer’s needs, the changing dynamics of industry compliance, regulatory requirements, emergence of value-based care and payment reforms necessitate the industry to seek new providers in the core administrative domain. Payers engage with members across various touchpoints, cutting through multiple lines of businesses and transactions using a wide range of payer platform modules enabled by cutting-edge technologies. By adopting an advanced cloud-based core administration solution, payers can better handle the operational functions with enhanced efficiency and a more robust technological stack. This compendium provides comprehensive and fact-based snapshots of 14 healthcare core administration platforms providers. Each profile specifies the provider’s position on Everest Group’s PEAK Matrix® and offers an insightful analysis of its capabilities. The compendium will enable providers to benchmark their capabilities against their peers, while buyers will be able to assess the providers based on their desired set of capabilities. Scope Industry: healthcare Geography: global Services: healthcare core administration platforms The assessment is based on Everest Group’s annual RFI process for the calendar year 2022, interactions with leading healthcare providers offering healthcare core administration platforms, client reference checks, and an ongoing analysis of the US healthcare CAPS market Contents In this report, we: Assess 14 healthcare cloud-based core administration platforms providers based on their capabilities and market success Provide enterprise sourcing considerations, highlighting providers’ key strengths and limitations Membership(s) Healthcare Payer and Provider Information Technology Sourcing and Vendor Management

The COVID-19 outbreak compelled the life sciences industry to innovate and transform digitally. However, the current global macroeconomic and socio-political uncertainty, coupled with increasing research and development IT expenditure, have created immense pressure on the pharmaceutical industry to expedite the drug discovery and development process while reducing resource consumption. As a result, pharmaceutical companies are prioritizing investments with the potential for quicker return on investment over moonshot investments. Legacy technologies lack the real-time or data integration capabilities that AI and analytics solutions offer, leading to a lack of visibility for pharmaceutical enterprises into the interplay among stakeholders in the life sciences technology landscape. This has caused pharmaceutical companies to partner with product and IT service providers to improve their in-house talent, reduce time-to-insights, replace obsolete models, and understand fast-evolving customer behavior. Although AI offers significant benefits, it presents unique challenges such as the availability and quality of training datasets from multiple sources, a demand-supply mismatch for talent with industry and technology expertise, and infrastructure and complex integration issues. Therefore, pharmaceutical companies need to prioritize use cases based on specific market requirements and business needs. In this report, we discuss how a blueprint for success can enable enterprises to maximize the value of their AI-empowered initiatives and investments. Scope Industry: life sciences Geography: global Contents In this report, we examine: The current state of AI in the pharmaceutical industry Trends driving the adoption of AI across the pharmaceutical value chain Roadblocks and controversies around AI in the pharmaceutical industry Prominent AI use cases across the pharmaceutical value chain Sourcing considerations for AI solutions and suppliers Membership(s) Life Sciences Information Technology Sourcing and Vendor Management

Health plans and payer organizations rely on core administration platforms as the foundation of their operations. These platforms facilitate efficient execution of core operational and administrative functions such as benefits administration, claims processing, member enrollment, claims payment and adjustments, and product management for benefits and product lines. However, the legacy Core Administrative Processing Solutions (CAPS) are inadequate in keeping up with the rapidly evolving delivery and implementation options and IT systems integration. These systems have been stable and reliable for decades, but are often highly customized to the client’s requirements and are hosted on premises. As a result, there is significant inertia in transitioning from legacy solutions to modern cloud-based core administration solutions due to the associated risks and efforts required. The healthcare industry is now seeking new vendor partnerships due to the rapidly evolving industry compliance and regulatory requirements, challenges and opportunities for payment reform, and the emergence of value-based care. In this report, we assess 14 healthcare core administration platform providers and position them on Everest Group’s PEAK Matrix® as Leaders, Major Contenders, and Aspirants based on their vision and capability and market impact. The report also outlines the strengths and limitations of each provider. Scope Industry: healthcare Geography: US The assessment is based on Everest Group’s annual RFI process for the calendar year 2022, interactions with leading healthcare core administrative processing platform providers, client reference checks, and an ongoing analysis of the US healthcare CAPS market Contents In this report, we examine: 14 healthcare core administration platform providers featured on the Healthcare Cloud-based Core Administration Platforms PEAK Matrix®. The assessment is based on Everest Group’s annual RFI process for the calendar year 2022, interactions with leading healthcare core administrative processing platform providers, client reference checks, and ongoing analysis of the US healthcare CAPS market The characteristics of Leaders, Major Contenders and Aspirants and assessment of capabilities of all the platform providers In-depth analysis of sourcing considerations for each of the platforms assessed Membership(s) Healthcare Payer and Provider Information Technology Sourcing and Vendor Management

The healthcare industry is experiencing unprecedented digital transformation. A large number of providers, payers, and public health organizations are designing their digital modernization strategies with the aim to migrate from legacy systems to new technologies for increased efficiency, reduced overhead costs, minimization of manual efforts, and successful remote collaboration. The digital transformation has created ample opportunities for IT service providers and product vendors as organizations look to implement their transformation roadmaps in the long and the short term. One such nascent, developing areas is high performance computing and has encouraged the most dominant and largest tech companies (which we refer to as Big Tech in this report), such as Amazon, Google, Microsoft, Oracle, and Salesforce, to foray into the healthcare industry. In this report, we examine the attempts made by these Big Tech vendors to gain a stronger foothold in the healthcare industry and their short- and long-term strategies around their offerings and capabilities. We also provide a comparative assessment of these vendors in terms of their value chain coverage, vision and strategy, client reach, and market activity. Scope: Services: digital services Industry: healthcare information technology Geography: global Contents: In this report, we: Analyze the rise of the Big Tech in healthcare Provide a comparative assessment of the Big Tech in healthcare Discuss healthcare industry cloud Examine Big Tech vendors’ recent M&As and related controversies Membership(s) Healthcare Payer and Provider Information Technology Sourcing and Vendor Management